Bee Koen Low

Kelso Pharma has appointed Bee Koen Low as Chief Operating Officer

Kelso Pharma has announced the appointment of Bee Koen Low as its first Chief Operating Officer.

Low brings more than 20 years of pharmaceutical industry experience to the role, which she takes on after most recently serving as Director of Operations Diligence and Integration at Advanz Pharma.

Low held a number of other leadership positions over more than a decade at Advanz, focusing on project management, technical operations, and operations diligence and integration.

Prior to this, Low worked at GW Pharmaceuticals, now part of Jazz Pharmaceuticals, where she played a key role in advancing the company’s product pipeline development as Pharmaceutical Development Team Leader.

Commenting on her latest venture, Low said: “It’s an incredibly exciting time to be joining the Kelso Pharma team… I’m looking forward to playing a key role in supporting our team continue to grow the business across Europe, as we aim to support as many patients as we can.”

Kelso’s Chief Executive Officer, Tom Stratford, added: “As Kelso Pharma continues to grow in the UK and across Europe, it’s vital we build a leadership team that can take us to the next level… I’m looking forward to working with Bee as we build a truly pan European pharma business.”